330 related articles for article (PubMed ID: 24630518)
21. CD 133+ and CXCR4+ colon cancer cells as a marker for lymph node metastasis.
Silinsky J; Grimes C; Driscoll T; Green H; Cordova J; Davis NK; Li L; Margolin DA
J Surg Res; 2013 Nov; 185(1):113-8. PubMed ID: 23777983
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma.
Sun J; Chen LJ; Zhang GB; Jiang JT; Zhu M; Tan Y; Wang HT; Lu BF; Zhang XG
Cancer Immunol Immunother; 2010 Aug; 59(8):1163-71. PubMed ID: 20333377
[TBL] [Abstract][Full Text] [Related]
23. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration.
Hu X; Xu M; Hu Y; Li N; Zhou L
Cell Biochem Biophys; 2021 Jun; 79(2):397-405. PubMed ID: 33743142
[TBL] [Abstract][Full Text] [Related]
24. Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.
Galizia G; Gemei M; Del Vecchio L; Zamboli A; Di Noto R; Mirabelli P; Salvatore F; Castellano P; Orditura M; De Vita F; Pinto M; Pignatelli C; Lieto E
Arch Surg; 2012 Jan; 147(1):18-24. PubMed ID: 22250106
[TBL] [Abstract][Full Text] [Related]
25. [Expression characteristics and clinical significance of B7-H3 in colorectal cancer].
Shao Y; Shi T; Guo L; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):435-442. PubMed ID: 38790100
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.
Kojima M; Ishii G; Atsumi N; Fujii S; Saito N; Ochiai A
Cancer Sci; 2008 Aug; 99(8):1578-83. PubMed ID: 18754869
[TBL] [Abstract][Full Text] [Related]
27. Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients.
Takahashi S; Kamiyama T; Tomaru U; Ishizu A; Shida T; Osaka M; Sato Y; Saji Y; Ozaki M; Todo S
Oncol Rep; 2010 Nov; 24(5):1201-12. PubMed ID: 20878111
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells.
Zhang P; Chen Z; Ning K; Jin J; Han X
Biochem Biophys Res Commun; 2017 Aug; 490(3):1132-1138. PubMed ID: 28676400
[TBL] [Abstract][Full Text] [Related]
29. CD133 expression is an independent prognostic marker for low survival in colorectal cancer.
Horst D; Kriegl L; Engel J; Kirchner T; Jung A
Br J Cancer; 2008 Oct; 99(8):1285-9. PubMed ID: 18781171
[TBL] [Abstract][Full Text] [Related]
30. CD133 gene overexpression is frequently observed in early colorectal carcinoma.
Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Hepatogastroenterology; 2009; 56(93):995-7. PubMed ID: 19760928
[TBL] [Abstract][Full Text] [Related]
31. Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer.
Wang L; Zhao Y; Xu M; Zhou F; Yan J
J BUON; 2019; 24(3):1120-1127. PubMed ID: 31424670
[TBL] [Abstract][Full Text] [Related]
32. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
[TBL] [Abstract][Full Text] [Related]
33. CD133 expression is correlated with poor prognosis in colorectal cancer.
Kashihara H; Shimada M; Kurita N; Iwata T; Sato H; Kozo Yoshikawa ; Higashijima J; Chikakiyo M; Nishi M; Matsumoto N
Hepatogastroenterology; 2014 Sep; 61(134):1563-7. PubMed ID: 25436343
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
35. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.
Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W
Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361
[TBL] [Abstract][Full Text] [Related]
36. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
Huang X; Sheng Y; Guan M
Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578
[TBL] [Abstract][Full Text] [Related]
37. Exosomal B7-H3 facilitates colorectal cancer angiogenesis and metastasis through AKT1/mTOR/VEGFA pathway.
Wu R; Zhang Y; Xu X; You Q; Yu C; Wang W; Mao Y
Cell Signal; 2023 Sep; 109():110737. PubMed ID: 37263461
[TBL] [Abstract][Full Text] [Related]
38. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X
Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of B7-H3 in CD14+ monocytes is associated with renal cell carcinoma progression.
Li M; Zhang G; Zhang X; Lv G; Wei X; Yuan H; Hou J
Med Oncol; 2014 Dec; 31(12):349. PubMed ID: 25416051
[TBL] [Abstract][Full Text] [Related]
40. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
